Keywords: Germany, Health care, Personalized medicines, New drug uptake, Rebates

Lilly CEO tells German audience there is a need for shift in thinking on health reform; says German uptake of new drugs slow

Article | 25 March 2010

Print This

In an address to the American Chamber of Commerce in Germany today, US drug major Eli Lilly’s chairman and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in